Pages that link to "Q42133869"
Jump to navigation
Jump to search
The following pages link to Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. (Q42133869):
Displaying 50 items.
- Neoatherosclerosis: Coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosis (Q26774540) (← links)
- Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks (Q26775130) (← links)
- Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014 (Q26785321) (← links)
- Biomechanical Modeling to Improve Coronary Artery Bifurcation Stenting: Expert Review Document on Techniques and Clinical Implementation (Q26796496) (← links)
- Recent advances in drug eluting stents (Q27025538) (← links)
- The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence (Q28067509) (← links)
- Endothelial repair in stented arteries is accelerated by inhibition of Rho-associated protein kinase (Q30832055) (← links)
- Preclinical study of a biodegradable polymer-based stent with abluminal sirolimus release. (Q33733393) (← links)
- Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis (Q33791885) (← links)
- Everolimus-eluting stents improve vascular response in a diabetic animal model (Q34076128) (← links)
- Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis (Q34452943) (← links)
- Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo (Q34505823) (← links)
- Simulation of the microscopic process during initiation of stent thrombosis (Q34758865) (← links)
- Enhancing physiologic simulations using supervised learning on coarse mesh solutions (Q35134338) (← links)
- Design of a pulsatile flow facility to evaluate thrombogenic potential of implantable cardiac devices (Q35140316) (← links)
- Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor (Q35532690) (← links)
- Endothelial retention and phenotype on carbonized cardiovascular implant surfaces. (Q35642221) (← links)
- Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience (Q35787354) (← links)
- Constraining OCT with Knowledge of Device Design Enables High Accuracy Hemodynamic Assessment of Endovascular Implants (Q35932511) (← links)
- Degree of bioresorbable vascular scaffold expansion modulates loss of essential function (Q36096161) (← links)
- Extent of flow recirculation governs expression of atherosclerotic and thrombotic biomarkers in arterial bifurcations. (Q36349802) (← links)
- A Comparison of Fully-Coupled 3D In-Stent Restenosis Simulations to In-vivo Data (Q36394513) (← links)
- The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia (Q36417926) (← links)
- Coronary stent thrombosis: current insights into new drug-eluting stent designs (Q36514842) (← links)
- Clinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the FLEX Registry. (Q36602870) (← links)
- Hemodynamics in Idealized Stented Coronary Arteries: Important Stent Design Considerations (Q36610239) (← links)
- Sustained Efficacy and Arterial Drug Retention by a Fast Drug Eluting Cross-Linked Fatty Acid Coronary Stent Coating (Q36619550) (← links)
- First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry). (Q37021327) (← links)
- One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium ste (Q37043053) (← links)
- Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial (Q37090890) (← links)
- Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery (Q37094848) (← links)
- Blood compatibility assessment of polymers used in drug eluting stent coatings (Q37238906) (← links)
- Tailoring biomaterial surface properties to modulate host-implant interactions: implication in cardiovascular and bone therapy. (Q37249147) (← links)
- Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis. (Q37284036) (← links)
- Computational simulation of platelet interactions in the initiation of stent thrombosis due to stent malapposition (Q37289877) (← links)
- Effects of Low Endothelial Shear Stress After Stent Implantation on Subsequent Neointimal Hyperplasia and Clinical Outcomes in Humans (Q37364362) (← links)
- Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans (Q37561357) (← links)
- Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction (Q37602754) (← links)
- Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease (Q37641238) (← links)
- Anticoagulation in neurointerventions: basic pharmacology and pathophysiology, current status, practical advice (Q37981910) (← links)
- Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction (Q37987875) (← links)
- Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. (Q37996688) (← links)
- Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses (Q38003373) (← links)
- Engineered arterial models to correlate blood flow to tissue biological response. (Q38006733) (← links)
- Outcomes of prosthetic hemodialysis grafts after deployment of bare metal versus covered stents at the venous anastomosis (Q38010042) (← links)
- The importance of the endothelium in atherothrombosis and coronary stenting (Q38012002) (← links)
- Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation. (Q38063290) (← links)
- New concepts in the design of drug-eluting coronary stents (Q38082647) (← links)
- The effects of stenting on shear stress: relevance to endothelial injury and repair. (Q38099637) (← links)
- Pharmacotherapy for the reduction of stent thrombosis (Q38101963) (← links)